Follow
Anneke Van Der Walt
Anneke Van Der Walt
Associate Professor, Central Clinical School, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Neurocognitive effects of adjunctive levetiracetam in children with partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, noninferiority trial
PM Levisohn, M Mintz, SJ Hunter, H Yang, J Jones, ...
Epilepsia 50 (11), 2377-2389, 2009
1142009
Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions
A Klistorner, P Sriram, N Vootakuru, C Wang, MH Barnett, R Garrick, ...
Neurology 82 (24), 2165-2172, 2014
1052014
Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis
S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ...
Neurology 97 (19), e1870-e1885, 2021
822021
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor
A Van Der Walt, S Sung, T Spelman, M Marriott, S Kolbe, P Mitchell, ...
Neurology 79 (1), 92-99, 2012
702012
Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade
A Van der Walt, H Butzkueven, S Kolbe, M Marriott, E Alexandrou, ...
Pharmacology & therapeutics 126 (1), 82-93, 2010
702010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
CJ Jensen, J Stankovich, A Van der Walt, M Bahlo, BV Taylor, ...
PloS one 5 (4), e10003, 2010
632010
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
A van der Walt, J Stankovich, M Bahlo, BV Taylor, IAF Van Der Mei, ...
Neurology 73 (13), 1018-1025, 2009
532009
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
F Tea, JA Lopez, S Ramanathan, V Merheb, FXZ Lee, A Zou, D Pilli, ...
Acta neuropathologica communications 7 (1), 1-22, 2019
502019
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes
A Van Der Walt, SC Kolbe, YE Wang, A Klistorner, N Shuey, G Ahmadi, ...
PLoS One 8 (12), e83825, 2013
502013
Technologies for advanced gait and balance assessments in people with multiple sclerosis
CJ Shanahan, FMC Boonstra, LE Cofré Lizama, M Strik, BA Moffat, ...
Frontiers in neurology 8, 708, 2018
492018
COVID-19 in people with multiple sclerosis: a global data sharing initiative
LM Peeters, T Parciak, C Walton, L Geys, Y Moreau, E De Brouwer, ...
Multiple Sclerosis Journal 26 (10), 1157-1162, 2020
482020
What speech can tell us: A systematic review of dysarthria characteristics in Multiple Sclerosis
G Noffs, T Perera, SC Kolbe, CJ Shanahan, FMC Boonstra, A Evans, ...
Autoimmunity reviews 17 (12), 1202-1209, 2018
482018
Fibre-specific white matter changes in multiple sclerosis patients with optic neuritis
S Gajamange, D Raffelt, T Dhollander, E Lui, A van der Walt, T Kilpatrick, ...
NeuroImage: Clinical 17, 60-68, 2018
482018
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
MM Gresle, Y Liu, LF Dagley, J Haartsen, F Pearson, AW Purcell, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1209-1213, 2014
452014
Risk of secondary progressive multiple sclerosis: a longitudinal study
A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ...
Multiple Sclerosis Journal 26 (1), 79-90, 2020
442020
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition
A Van der Walt, J Stankovich, M Bahlo, BV Taylor, IAF Van der Mei, ...
Multiple Sclerosis Journal 17 (3), 344-352, 2011
442011
Diffusion tensor imaging correlates of visual impairment in multiple sclerosis and chronic optic neuritis
SC Kolbe, M Marriott, A Van Der Walt, J Fielding, A Klistorner, PJ Mitchell, ...
Investigative ophthalmology & visual science 53 (2), 825-832, 2012
402012
Multifocal VEP assessment of optic neuritis evolution
D Alshowaeir, C Yannikas, R Garrick, A Van Der Walt, SL Graham, ...
Clinical Neurophysiology 126 (8), 1617-1623, 2015
352015
Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years
T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, ...
Neurology 96 (5), e783-e797, 2021
332021
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
T Kalincik, T Spelman, M Trojano, P Duquette, G Izquierdo, P Grammond, ...
PloS one 8 (5), e63480, 2013
332013
The system can't perform the operation now. Try again later.
Articles 1–20